Professional Documents
Culture Documents
))
Various sources: Various sources:
NO synthase NO synthase
NAD(P)H oxidase NAD(P)H oxidase
xanthine oxidase xanthine oxidase
mitochondrial mitochondrial
Lucigenib enhance Lucigenib enhance
chemiluminescence chemiluminescence
assy assy
Cytochrome c reduction Cytochrome c reduction
Urinary ONOO Urinary ONOO
TRAP (total radical TRAP (total radical
trapping potential in trapping potential in
palsma) palsma)
mitochondrial mitochondrial
oxidase oxidase
Perfused organ or Perfused organ or
neutrophil burst neutrophil burst
Sum of Sum of
antioxidant antioxidant
capacities (plasma capacities (plasma
or urine) or urine)
Spectrophotometry Spectrophotometry
Immunohistochemistry Immunohistochemistry
Mass spectrometry Mass spectrometry
Luminol Luminol
chemiluminescence chemiluminescence
Blendea MC, Winer N, Sowrs JR, 2006
F2-isoprostan
Meninggi pada Meninggi pada ::
Diabetes Diabetes
Dislipidemi Dislipidemi
ESRD ESRD ESRD ESRD
Obesitas tanpa komplikasi Obesitas tanpa komplikasi
Ateroklerosis Ateroklerosis
Stress Oksidatif yang Berkepanjangan Stress Oksidatif yang Berkepanjangan
Higdon & Frei,2003 Higdon & Frei,2003
Lymphocyte Vit. C in subjects with T2DM
Free Radicals
Anti Oxidant
Micro & Macrovascular
complication
Lymphocyte Vit. C in subjects with T2DM
in T2DM without complication
in T2DM with complication
Yamada, 2004
Diabetic Nephropathy
+ Vit. C, Vit. E
Mg, Zn Mg, Zn
Albuminuria
Farid, 2005
Diabetes status Diabetes status
Normal Normal
glucose glucose
tolerance tolerance
(n= 1145) (n= 1145)
Impaired Impaired
glucose glucose
metabolism metabolism
(n= 320) (n= 320)
Type 2 Type 2
diabetes diabetes
(n= 132) (n= 132)
PP for trend for trend
Serum carotenoids ( Serum carotenoids (mol/L) mol/L)
oo--carotene carotene 0.13 0.13 0.12 0.12 0.10 0.10 0.011 0.011
Diabetes and serum carotenoids: Population-based
study in Queensland, Australia
oo--carotene carotene 0.13 0.13
(0.10, 0.18) (0.10, 0.18)
0.12 0.12
(0.09, 0.16) (0.09, 0.16)
0.10 0.10
(0.08, 0.14) (0.08, 0.14)
0.011 0.011
||--carotene carotene 0.59 0.59
(0.47, 0.73) (0.47, 0.73)
0.50 0.50
(0.38, 0.64) (0.38, 0.64)
0.42 0.42
(0.30, 0.58) (0.30, 0.58)
0.01 0.01
||--cryptoxanthin cryptoxanthin 0.22 0.22
(0.19, 0.25) (0.19, 0.25)
0.20 0.20
(0.17, 0.23) (0.17, 0.23)
0.19 0.19
(0.16, 0.22) (0.16, 0.22)
0.041 0.041
Lutein/zeaxanthi Lutein/zeaxanthi
nn
0.42 0.42
(0.35, 0.50) (0.35, 0.50)
0.39 0.39
(0.35, 0.43) (0.35, 0.43)
0.35 0.35
(0.33, 0.38) (0.33, 0.38)
0.026 0.026
Lycopene Lycopene 0.44 0.44
(0.40, 0.49) (0.40, 0.49)
0.39 0.39
(0.34, 0.45) (0.34, 0.45)
0.35 0.35
(0.27, 0.44) (0.27, 0.44)
0.053 0.053
Coyne et al. AmJ Clin Nutr 2005;82:685-93
Increase of Human Plasma Antioxidant Capacity with
a Novel Formulation of Antioxidants
Ivonne Maria Olivares-Corichi1, Roberto Medina-Santilln2, Cecilia Fernndez
del Valle-Laisequilla2,Pndaro Alvarez2 and Juan Jos Hicks-Gomez2
Proc. West. Pharmacol. Soc. 46: 45-47 (2003)
GLUCOSE TOLERANCE FACTOR
RCT IN TYPE 2 DIABETES IN CHINA:
SUPPLEMENTAL CHROMIUM REDUCED
FASTING GLUCOSE, HbA1c, INSULIN, &
CHOLESTEROL LEVELS. ( ANDERSON,
CHENG, BRYDEN;1997) CHENG, BRYDEN;1997)
12 STUDIES REPORTED, CHROMIUM
SUPPLEMENTATION IMPROVED THE
EFFICIENCY OF INSULIN OR HAD
BENEFICIAL EFFECTS ON THE BLOOD
LIPID PROFILES
Thiamine deficiency in clinical diabetes linked
to renal dysfunction
27% decrease in plasma thiamine in type 1 diabetic patients; no
decrease in type 2 patients - Norway
(Haugen HN, Scand J Clin Lab Invest 16, 260-266, 1964)
76% of diabetic patients (7 type 1, 39 type 2) had plasma thiamine lower
than the normal range minimum Japan
(Saito N et al., J Nutr Sci Vitaminol 33, 421-430, 1987)
18% of 100 type 2 diabetic patients red blood cell TK activity lower than
the normal range minimum Israel
(Havivi E et al., Internat J Vit Nutr Res 61, 328-33, 1991).
Type 1 diabetic children (n = 10) with normal renal function had plasma
thiamine concentration deceased by 34%. Plasma thiamine
concentration was normalized by benzoxymethyl-thiamine, 50 mg/day
(Valerio G et al., Acta Diabetol 36, 73-76, 1999)
Diabetic patients are at risk of thiamine deficiency
Major Pathways in Hyperglycemic Damage
Vit. B1
Vit. B1-stimulated transketolase activity blocks deleterious pathways
Hexosamines:
insulin resist.
PKC activity
Polyol pathway:
oxidative stress
PKC activity
DAG pathway:
capill. vascul.
Hammes et al., Nature Medicine (2003) 9; 294-299
capill. vascul.
PKC activity
AGE formation:
capillary leak
oxygen supply
oxidative stress
damaging membranes
interfering w/ proteins
axoplasmic transp.
Starting point in mitochondria: GAP-DH
blocked by superoxide anion concentr.
Status vitamin & mineral pasien diabetes tipe 2
(Mooradian et all 1987)
Vitamin A Vitamin A
Vitamin C Vitamin C
Vitamin E Vitamin E
Vitamin B1 Vitamin B1 Vitamin B1 Vitamin B1
Vitamin B6 Vitamin B6 N/ N/
Vitamin B12 Vitamin B12 N/ N/
Magnesium Magnesium
Chromium Chromium //
Selenium Selenium
Zinc Zinc
Asam Folat Asam Folat
CONTAINING DEFICIENT NUTRIENTS IN
DIABETIC PATIENTS ONLY
Supplements in Type-2
Diabetes Mellitus
DIABETIC PATIENTS ONLY
DOSE IN AGREE WITH DAILY NORMAL
REQUIREMENTS
AVOID PROOXIDANT COMPOUNDS, SUCH
AS CUPPER AND IRON
AVOID VITAMIN K, BECAUSE INCREASES
BLOOD CLOTTING
SUPPLEMENTATION WITH ESSENTIAL
NUTRIENTS IN DIABETIC PATIENTS:
Restore the nutritive deficiency induced by the diabetic
state state
Increase the activity of antioxidant system
Vitamins Daily Requirements
Marion et al., Diabetes Care 25(1):148-198, 2002
Vitamin
Minimal
Requirement/day
Maximal
tolerated
Glucobion
700 g (m)
A
(retinol)
700 g (m)
900 g (h)
3000 g 1000 g
C
(ascorbate)
75 mg (m)
90 mg (h)
2000 mg 100 mg
E
(o-tocopherol)
15 mg 1000 mg 100 mg
Vitamin
Minimal
Requirement/day
Maximal dose
tolerated
Glucobion
B1
(thiamine)
1.1 mg (m)
1.3 mg (h)
insufficient
data
5 mg
Vitamins Daily Requirements
Marion et al., Diabetes Care 25(1):148-198, 2002
(thiamine)
1.3 mg (h) data
B6
(piridoxin)
1.3 mg 100 mg 5 mg
B12
(cobalamine)
2.4 g
insufficient
data
5 g
Folic Acid 400 g 1000 g 400 g
Minerals Daily Requirement
Marion et al., Diabetes Care 25(1):148-198, 2002
Mineral Mineral
Minimal Minimal
Requirement/day Requirement/day
Maximal Maximal
tolerated tolerated
Glucobion Glucobion
Chromium Chromium
25 25 g (m) g (m)
35 35 g (h) g (h)
Unknown Unknown
50 50 gg
Magnesium Magnesium
320 m 320 mg (m) g (m)
420 mg (h) 420 mg (h)
350 mg 350 mg 87.5 mg 87.5 mg
Selenium Selenium 55 55 gg 400 400 gg 70 70 gg
Zinc Zinc
8 mg (m) 8 mg (m)
11 mg (h) 11 mg (h)
40 mg 40 mg
15 m 15 mgg
GLUCOBION
AND DIABION